No-reflow phenomenon: Maintaining vascular integrity

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 16, Issue 3-4, 2011, Pages 244-250

  Kloner, Robert A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

acute myocardial infarction; heart disease; ischemia reperfusion injury; no reflow

Indexed keywords

ABCIXIMAB; ADENOSINE; ALBUMIN MICROSPHERE TC 99M; CALCIUM CHANNEL BLOCKING AGENT; NICORANDIL; NITROPRUSSIDE SODIUM; THALLIUM;

CELL STRUCTURE; CELL SWELLING; CELLULAR DISTRIBUTION; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DISEASE COURSE; ENDOTHELIUM CELL; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART VENTRICLE REMODELING; HUMAN; MICROEMBOLISM; MORTALITY; NO REFLOW PHENOMENON; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; SHOCK; THROMBECTOMY; VASODILATATION;

ANIMALS; CORONARY CIRCULATION; HUMANS; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; VENTRICULAR REMODELING;

EID: 80051540137     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248411405990     Document Type: Conference Paper

References (32)

1. Kloner RA, Ganote CE, Jennings RB. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974 ; 54 (6). 1496-1508
2. Summers WK, Jamison RL. The no-reflow phenomenon in renal ischemia. Lab Invest. 1971 ; 25 (6). 635-643
3. Majno G, Ames A, Chaing J, Wright RL. No-reflow after cerebral ischemia. Lancet. 1967 ; 2 (1). 569-570
4. Krug A, De Rochemont WM, Korb G. Blood supply of the myocardium after temporary coronary occlusion. Circ Res. 1966 ; 19 (1). 57-62
5. Kloner RA, Alker KJ. The effect of streptokinase on intramyocardial hemorrhage, infarct size, and the no-reflow phenomenon during coronary reperfusion. Circulation. 1984 ; 70 (3). 513-521 (Pubitemid 14068580)
6. Kloner RA, Alker K, Campbell C, Figures G, Eisenhauer A, Hale SL. Does tissue-type plasminogen activator have direct beneficial effects on the myocardium independent of its ability to lyse intracoronary thrombi?. Circulation. 1989 ; 79 (5). 1125-1136 (Pubitemid 19129196)
7. Hale SL, Dae M, Kloner RA. Hypothermia during reperfusion limits "no-reflow" injury in a rabbit model of acute myocardial infarction. Cardiovasc Res. 2003 ; 59 (3). 715-722 (Pubitemid 38368688)
8. Hale SL, Kloner RA. The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit. J Cardiovas Pharmacol Therap. 2008 ; 13 (3). 226-232
9. Reffelmann T, Kloner RA. Microvascular reperfusion injury: rapid expansion of anatomic no-reflow during reperfusion in the rabbit. Am J Physiol Heart Circ Physiol. 2002 ; 283 (3). H1099-H1107
10. Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation. 1989 ; 80 (6). 1846-1861 (Pubitemid 20031716)
11. Kloner RA, Rude RE, Carlson N, Maroko PR, DeBoer LWV, Braunwald E. Ultrastructural evidence of microvascular damage and myocardial cell injury following coronary artery occlusion: which comes first?. Circulation. 1980 ; 62 (5). 178-184
12. Reffelmann T, Hale SL, Dow JS, Kloner RA. No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion. Circulation. 2003 ; 108 (23). 2911-2917 (Pubitemid 37517820)
13. Reffelmann T, Kloner RA. The "no-reflow" phenomenon: basic science and clinical correlates. Heart. 2002 ; 87 (2). 162-168 (Pubitemid 34098385)
14. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation. 2002 ; 105 (5). 656-662 (Pubitemid 34123444)
15. Kloner RA. No-reflow: Basic science to clinical phenomenon. Basic Res Cardiol. 2006 ; 101 (9). 357-358 (Pubitemid 44275868)
16. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998 ; 97 (8). 765-772 (Pubitemid 28135339)
17. Judd RM, Lugo-Olivieri CH, Arai M, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation. 1995 ; 92 (7). 1902-1910
18. Kim RJ, Chen E, Lima JAC, et al. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation. 1996 ; 94 (12). 3318-3326 (Pubitemid 26427504)
19. Bekkers SCAM, Yazdani S, Virmani R, Waltenberger J. Microvascular obstruction. Underlying pathophysiology and clinical diagnosis. J Am Coll Cardiol. 2009 ; 54 (16). 281-292
20. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol. 2009 ; 54 (4). 281-292
21. Ndrepepa G, Tiroch K, Fusaro M, et al. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol. 2010 ; 55 (21). 2383-2389
22. Bolognese L, Carraba N, Parodi G, et al. Impact of microvascular dysfunction on left ventricular remodeling and long term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation. 2004 ; 109 (9). 1121-1126 (Pubitemid 38332616)
23. Heusch G, Kleinbongard P, Bose D, et al. Coronary microembolization. From bedside to bench and back to bedside. Circulation. 2009 ; 120 (18). 1822-1836
24. Rezkalla SH, Dharmashankar KC, Abdalrahman IB, Kloner RA. No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome and effect of pharmacologic therapy. J Interven Cardiol. 2010 ; 23 (5). 429-436
25. Galiuto L, Garramone B, Scuia A, et al. The effect of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the multicenter AMICI study. J Am Coll Cardiol. 2008 ; 51 (5). 552-559
26. Svilaas T, Vlaar PJ, Van der Horst IC, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008 ; 358 (6). 557-567 (Pubitemid 351214283)
27. Jaffe R, Dick A, Strauss BH. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention. A systematic approach. J Am Coll Cardiol Interven. 2010 ; 3 (7). 695-704
28. Micari A, Belick TA, Balcells EA, et al. Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting. Am J Cardiol. 2005 ; 96 (10). 1410-1415 (Pubitemid 41566624)
29. Forman MB, Hou D, Jackson EK. Treating acute "no-reflow" with intracoronary adenosine in 4 patients during percutaneous coronary intervention. Tex Heart Inst J. 2008 ; 35 (4). 439-446
30. Przyklenk K, Kloner RA. Reperfusion injury by oxygen-free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow. Circ Res. 1989 ; 64 (1). 86-96 (Pubitemid 19028506)
31. Reffelmann T, Kloner RA. The no-reflow phenomenon: a basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol. 2006 ; 101 (5). 359-372 (Pubitemid 44275869)
32. Reffelmann T, Kloner RA. Microvascular alterations after temporary coronary artery occlusion: the no-reflow phenomenon. J Cardiovasc Pharmacol Therap. 2004 ; 9 (3). 163-172 (Pubitemid 39331062)